We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTRA
476
DELISTED
Coterra Energy
CTRA
| $25M | 0.03% |
1,149,092
+264,393
| +30% | +$4.53M |
|
477
Deckers Outdoor
DECK
$13.3B
| $25M | 0.03% |
416,190
-16,512
| -4% | -$1.13M |
|
478
Knight Transportation
KNX
$11.4B
| $24.9M | 0.03% |
485,989
+108,209
| +29% | +$5.44M |
|
479
Five Below
FIVE
$13.5B
| $24.7M | 0.03% |
139,905
-1,182
| -0.8% | -$235K |
|
480
JB Hunt Transport Services
JBHT
$25.2B
| $24.6M | 0.03% |
147,357
-9,437
| -6% | -$1.61M |
|
481
Arrow Electronics
ARW
$10.4B
| $24.6M | 0.03% |
218,892
-11,645
| -5% | -$1.35M |
|
482
Lear
LEA
$8.18B
| $24.5M | 0.03% |
156,358
+3,650
| +2% | +$597K |
|
483
AptarGroup
ATR
$8.61B
| $24.4M | 0.03% |
204,083
-2,970
| -1% | -$391K |
|
484
Advance Auto Parts
AAP
$3.49B
| $24.3M | 0.03% |
116,098
+12,890
| +12% | +$2.69M |
|
485
J.M. Smucker
SJM
$12.8B
| $24.2M | 0.03% |
201,950
+12,504
| +7% | +$1.59M |
|
486
First Solar
FSLR
$26.9B
| $24.1M | 0.03% |
252,900
+12,264
| +5% | +$1.14M |
|
487
Middleby
MIDD
$6.08B
| $24.1M | 0.03% |
141,529
-3,962
| -3% | -$716K |
|
|
SPLK
488
DELISTED
Splunk Inc
SPLK
| $24.1M | 0.03% |
166,429
-2,108
| -1% | -$307K |
|
489
Neurocrine Biosciences
NBIX
$16.6B
| $24.1M | 0.03% |
251,063
-926
| -0.4% | -$87.5K |
|
490
KKR & Co
KKR
$92.3B
| $24M | 0.03% |
394,477
-37,662
| -9% | -$2.37M |
|
491
Dentsply Sirona
XRAY
$2.43B
| $24M | 0.03% |
413,575
+1,704
| +0.4% | +$105K |
|
492
UGI
UGI
$7.33B
| $23.8M | 0.03% |
558,843
-23,256
| -4% | -$1.06M |
|
493
Owens Corning
OC
$12.4B
| $23.7M | 0.03% |
276,850
-11,623
| -4% | -$1.09M |
|
494
Crocs
CROX
$6.55B
| $23.7M | 0.03% |
164,960
-8,504
| -5% | -$1.17M |
|
495
Jabil
JBL
$35.8B
| $23.5M | 0.03% |
402,753
+14,115
| +4% | +$839K |
|
496
Wolfspeed
WOLF
$1.71B
| $23.5M | 0.03% |
291,099
-10,506
| -3% | -$933K |
|
497
Penumbra
PEN
$12.8B
| $23.5M | 0.03% |
88,033
-82
| -0.1% | -$22K |
|
|
XEC
498
DELISTED
CIMAREX ENERGY CO
XEC
| $23.4M | 0.03% |
268,673
-8,315
| -3% | -$577K |
|
499
Snap-on
SNA
$21.5B
| $23.4M | 0.03% |
111,869
-879
| -0.8% | -$195K |
|
500
Encompass Health
EHC
$12.4B
| $23.4M | 0.03% |
391,314
+4,559
| +1% | +$287K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.